Researchers have developed and validated a simple “peel-and-sniff” test that can be completed unsupervised at home to screen for cognitive impairment. It’s well known that impaired olfactory function ...

Among people who report memory and thinking problems, some show no signs of a problem on standard tests, while others have subtle declines on their tests. A new study shows that people who have subtle ...

There's been a flurry of attention around a new study in Frontiers in Neurology validating that the Brain Care Score, or BCS, may help in assessing one's risk of developing dementia or having a stroke ...

Mike Davis’ mother died from Alzheimer’s disease in 2008. So when Davis started noticing that he was having an increasing number of “senior moments” at age 76 — such as forgetting to water his plants, ...

Panelists discuss how managing patients with mild cognitive impairment using amyloid-targeting therapies faces significant barriers including limited healthcare infrastructure for complex diagnostic ...

Neuropsychological assessment, or cognitive testing, is the gold standard tool for measuring cognitive functions (or the “software” of the brain) such as memory, language, attention, visuospatial ...

The Florey Dementia Index predicted when cognitive decline or Alzheimer's dementia would occur. The index is based on age and dementia severity test scores. The model performed well in several cohorts ...

Researchers say this breakthrough could lead to more effective prevention strategies and future therapies. Study: The plasma miRNAome in ADNI: Signatures to aid the detection of at-risk individuals.

Pharmacy and supermarket shelves are overflowing with herbal supplements, potions, and pills that make lofty health and wellness promises. Some supplements have proven benefits, others are little more ...

"For the first time, we found that empagliflozin, an established diabetes and heart medication, reduced markers of brain ...